Aakaar Medical Technologies Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | June 20, 2025 to June 24, 2025 |
| Listing Date | - |
| Face Value | ₹ 10 per share |
| Issue Price Band | ₹ 68 to ₹ 72 per share |
| Lot Size | 1,600 Shares |
| Total Issue Size (Ex Market Maker) | 37,50,400 shares (aggregating up to ₹ 27.00 Cr) |
| Fresh Issue (Ex Market Maker) | 37,50,400 shares (aggregating up to ₹ 27.00 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,04,22,416 shares |
| Share Holding Post Issue | 1,41,72,816 shares |
| Market Maker Portion | 1,88,800 shares |
About Aakaar Medical Technologies Limited IPO
Aakaar Medical Technologies Limited is launching its IPO with a fresh issue of ₹27 crore, offering 37,52,000 equity shares at a price band of ₹68 to ₹72 per share. The IPO is opening on June 20, 2025 with a closing on June 24, 2025. Retail investors will require a minimum investment of ₹1,15,200 to purchase the lot size of 1,600 shares. Shares will be listed on NSE on June 27, 2025.
Company Background
Founded in 2013 by Dilip Ramesh Meswani, Aakaar Medical Technologies Limited specializes in medical aesthetics, focusing on cosmetic products and devices. The company operates primarily in the B2B segment, supplying its offerings to dermatologists, plastic surgeons, and aesthetic physicians across India. Over the years, Aakaar has established a robust presence in the professional skincare, injectables, hair care, and aesthetic devices market.
Operations & Product Range
Facility & Production:
Aakaar Medical Technologies does not own manufacturing facilities but develops its brands through third-party or licensed manufacturing arrangements. The company partners with Parekh Integrated Services Pvt. Ltd. (PISPL) for logistics, utilizing 21 warehousing centers across India for distribution.
Brands & Market Presence:
The product portfolio includes both proprietary brands (domestically manufactured or sourced) and premium imported brands from countries such as South Korea, Spain, Italy, and Austria. The company has offered 154 SKUs and sold over 5.4 lakh units in FY 2024-25. The company has a customer base of more than 5,200 dermatologists and clinic chains across 15 Indian states.
Revenue Channels
Aakaar operates two main revenue channels:
- Imported Brands: Distribution of international aesthetic products and devices, contributing about 62–70% of revenue in recent years.
- Own Brands: Domestically produced products, either under white labeling or loan licensing, accounting for 30–38% of revenue.
- The company’s revenues have grown significantly, from ₹32.78 crore in FY23 to ₹61.58 crore in FY25.
Management & Shareholding
Promoters:
Dilip Ramesh Meswani and Bindi Dilip Meswani are the Promoters of the company and they are holding 91.11% shares in the company before the IPO.
Board Members:
The company is led by Dilip Meswani, who brings over 25 years of experience in the aesthetics industry.
IPO Objectives
The primary objective of the IPO is to raise fresh capital to fund working capital requirements, with 75% of the proceeds earmarked for this purpose. The remainder will be used for general corporate purposes.
Conclusion
Aakaar Medical Technologies Limited has established itself as a key player in the Indian medical aesthetics market, with a strong B2B focus, diversified product offerings, and robust distribution capabilities. The IPO aims to support the company's next phase of growth by strengthening its working capital base. Investors may find the company’s consistent financial performance, experienced leadership, and expanding market presence attractive, though risks such as reliance on imported brands and geographic concentration should be considered.
Aakaar Medical Technologies Limited IPO Financial Information
Latest Revenue
61.76
₹ Crore
Profit After Tax
6.04
₹ Crore
Net Worth
23.2
₹ Crore
Total Borrowing
22.74
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Total Borrowing | ||||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 51.85 | 61.76 | 6.04 | 23.2 | 22.74 | ||||
| 31 Mar 2024 | 34.01 | 46.27 | 3 | 12.53 | 15.06 | ||||
| 31 Mar 2023 | 23.23 | 32.88 | 2.15 | 9.66 | 5.87 | ||||
| Amount in ₹ Crore | |||||||||
Aakaar Medical Technologies Limited Key Performance Indicator
| KPI | Values |
|---|---|
| ROCE | 21.02% |
| Debt/Equity | 0.98 |
| RoNW | 33.81% |
| PAT Margin | 9.81% |
| EBITDA Margin | 15.81% |
| Price to Book Value | 5.23 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 5.79 | 4.26 |
| P/E (x) | 12.43 | 16.9 |
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Experienced Leadership
Diversified Product Portfolio
Pan-India Distribution
Strong Financial Growth
Large and Growing Customer Base
Download regulatory filings
Aakaar Medical Technologies Limited IPO Timeline
| IPO Open Date | Fri, Jun 20, 2025 |
| IPO Close Date | Tue, Jun 24, 2025 |
| Tentative Allotment | Wed, Jun 25, 2025 |
| Initiation of Refunds | Thu, Jun 26, 2025 |
| Credit of Shares to Demat | Thu, Jun 26, 2025 |
| Tentative Listing Date | Fri, Jun 27, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on June 24, 2025 |
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,15,200 |
| Retail (Max) | 1 | 1600 | ₹1,15,200 |
| HNI (Min) | 2 | 3200 | ₹2,30,400 |